Lecture by Kathy Herbst recorded on November 7th, 2020.
This template is applicable to most studies, including observational studies, pre/post-intervention studies, case/control studies, biological sample collection, qualitative studies, cross-sectional studies, and studies that randomized into standard of care treatment. This template should NOT be used for studies which involve new investigative drugs or devices. These types of studies require an expanded protocol with additional detail such as dosing, reporting of adverse events, etc.
Which one is right? This article will help you decide the best way to report your data in table format.
Scale development and validation are critical to much of the work in the health, social, and behavioral sciences. However, few researchers have the education or skill set to rigorously develop these useful tools. The following article provides steps to both develop and validate scales.
Jaykavan Charan published this informative paper in the Journal of Pharmaceutical Results. The paper discusses types and distribution of data as well as the aim of the study. The paper also includes a handy diagram on which statistical test to use based on data type/distribution.
Andrew Vickers and Daniel Sjoherg published an excellent set of guidelines to follow when reporting statistics in European Urology.